John C. Martin
2014 - Gilead Sciences
In 2014, John C. Martin earned a total compensation of $19M as Chairman and Chief Executive Officer at Gilead Sciences, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,717,365 |
|---|---|
| Option Awards | $5,241,907 |
| Salary | $1,605,017 |
| Stock Awards | $8,386,205 |
| Other | $7,500 |
| Total | $18,957,994 |
Martin received $8.4M in stock awards, accounting for 44% of the total pay in 2014.
Martin also received $3.7M in non-equity incentive plan, $5.2M in option awards, $1.6M in salary and $7.5K in other compensation.
Rankings
In 2014, John C. Martin's compensation ranked 138th out of 13,032 executives tracked by ExecPay. In other words, Martin earned more than 98.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 138 out of 13,032 | 99th |
Division Manufacturing | 52 out of 4,967 | 99th |
Major group Chemicals And Allied Products | 21 out of 1,690 | 99th |
Industry group Drugs | 18 out of 1,369 | 99th |
Industry Biological Products, Except Diagnostic Substances | 1 out of 241 | 100th |
Source: SEC filing on March 28, 2016.
Martin's colleagues
We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2014.